Put Options

8 transactions
Quarter Operation Price Per put puts change puts Held SEC Form
Q2 2024

Aug 14, 2024

SELL
$16.0 - $21.1 $6.19 Million - $8.16 Million
-386,800 Reduced 97.53%
9,800 $162,000
Q1 2024

May 15, 2024

BUY
$20.64 - $25.45 $7.99 Million - $9.85 Million
387,000 Added 4031.25%
396,600 $8.48 Million
Q4 2023

Feb 14, 2024

SELL
$21.06 - $27.57 $749,736 - $981,492
-35,600 Reduced 78.76%
9,600 $230,000
Q3 2023

Nov 14, 2023

BUY
$27.56 - $35.7 $316,940 - $410,550
11,500 Added 34.12%
45,200 $1.26 Million
Q2 2023

Aug 14, 2023

SELL
$31.53 - $39.74 $952,206 - $1.2 Million
-30,200 Reduced 47.26%
33,700 $1.14 Million
Q1 2023

May 15, 2023

SELL
$32.84 - $42.5 $3.17 Million - $4.11 Million
-96,600 Reduced 60.19%
63,900 $2.61 Million
Q4 2022

Feb 14, 2023

BUY
$32.54 - $37.99 $4.11 Million - $4.79 Million
126,200 Added 367.93%
160,500 $5.41 Million
Q3 2022

Nov 14, 2022

BUY
$32.81 - $41.51 $495,431 - $626,801
15,100 Added 78.65%
34,300 $1.13 Million

Others Institutions Holding NVST

About Envista Holdings Corp


  • Ticker NVST
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Instruments & Supplies
  • Shares Outstandng 163,391,008
  • Market Cap $3.16B
  • Description
  • Envista Holdings Corporation, together with its subsidiaries, engages in the development, sale, and marketing of dental products in the United States, China, and internationally. The company operates in two segments, Specialty Products & Technologies and Equipment & Consumables. The company's Specialty Products & Technologies segment...
More about NVST
Track Ken Griffin's Portfolio

Track Ken Griffin Portfolio

Follow Ken Griffin (Citadel Advisors LLC) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Citadel Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Citadel Advisors LLC and Ken Griffin with notifications on news.